On July 10, 2025, the Food and Drug Administration (FDA) announced that it had published more than 200 complete response letters (CRLs), in response to applications submitted to the FDA for approval of drugs or biological...more
SPAC Companies May Need to Evaluate Stock Structure in Wake of Delaware Court of Chancery Ruling -
Companies that previously became public by merger with a Special Purpose Acquisition Company (“SPAC”) may need to...more